glutathione liposomak Liposomal for Immune Support Liposomal Glutathione
Description
10.1093/ps/82.11.1747 40

A prospective, placebo-controlled, randomized, single-blind phase II trial was conducted in a multidisciplinary university hospitals ICU where two groups of patients with systemic inflammatory response syndrome aged more than 18 years were randomized to receive either placebo or intravenous Se as a bolus-loading dosage of 2000 g Se followed by a continuous infusion of 1600 g Se per day for ten days, the study revealed that Se supplementation improved illness severity, and reduces the risk of VAP [90]

PubMed, Deng, Z., et al

Nightly red light treatment significantly enhanced the resistance and this effect correlated with increased SA accumulation, defense-related gene transcription and reduced redox homeostasis
